✦ LIBER ✦

Benefits of lipid-lowering agents in stroke and coronary heart disease: Pharmacoeconomics

✍ Scribed by Stanley G. Rockson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensified Lipid-Lowering Therapy in Co

✍ Erland Erdmann 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 95 KB

SLCO1B1 521T→C functional genetic polymo

✍ Wei Zhang; Bi-Lian Chen; Vural Ozdemir; Yi-Jing He; Gan Zhou; Dao-Di Peng; Sheng 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

The 223A>G polymorphism of the leptin re

✍ Yan-Ming Sun; Lan-Feng Wang; Jia Li; Zhu-Qin Li; Wei Pan 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 112 KB

EFFECT OF R219K POLYMORPHISM OF THE ABCA

✍ Jia Li; Lan-Feng Wang; Zhu-Qin Li; Wei Pan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Utilization of cardiovascular drugs (blo

✍ J. Merlo; G. Lindberg; U. Lindblad; A. Lindgren; L. Råstam; A. Melander 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 108 KB

Effects of Fibrinogen on Lipid Peroxidat

✍ A. P. Savchenkova; L. B. Dudnik; I. L. Pogoretskaya; N. P. Solov'eva; M. A. Pokr 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 436 KB